The Nuix (ASX:NXL) share price zoomed 69% higher following its IPO

The Nuix Limited (ASX:NXL) share price has been in sensational form since landing on the ASX boards this afternoon…

| More on:
hand on touch screen lit up by a share price chart moving higher

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Nuix Limited (ASX: NXL) share price has surged higher on Friday after completing its highly anticipated initial public offering (IPO).

The analytics software provider's shares are up a massive 47% to $7.80 at the time of writing.

At one stage, the Nuix share price was up as much as 69.5% to $9.00.

What is Nuix?

Nuix is a leading provider of investigative analytics and intelligence software with a vision of "finding truth in a digital world."

It helps customers from around the world in many different industry verticals process, normalise, index, enrich, and analyse data from a multitude of different sources.

Its software has been used in a number of important investigations over the last decade and a half. This includes the Panama Papers, the Banking Royal Commission, organised crime rings, corporate scandals, and terrorist activities.

In FY 2020, Nuix reported a 25.9% increase in total revenue to $175.9 million. This revenue is largely from subscriptions, with subscription revenues now accounting for 88.7% of its total revenue.

This led to gross profit of $155.2 million and earnings before interest, tax, depreciation and amortisation (EBITDA) of $55.5 million.

Looking ahead, in FY 2021, management is forecasting total revenue of $193.5 million, gross profit of $166.7 million, and EBITDA of $63.6 million. This represents growth of 10%, 7.4%, and 14.6%, respectively.

The Nuix IPO.

Nuix was able to raise approximately $953 million through the issue of 179.5 million shares at an offer price of $5.31 per share.

It also raised proceeds of approximately $677.4 million for existing shareholders, such as Macquarie Group Ltd (ASX: MQG), through the sale of approximately 127.6 million shares at the same price.

These funds will be used to repay existing debt and provide funding and financial flexibility to support its growth strategy and future growth opportunities.

Chairman Jeff Bleich commented: "Nuix's growth strategy seeks to expand its presence across geographies and in targeted industry verticals by winning new customers, employing an industry‑centric "land and expand" strategy across industry verticals, continued investment in functionality of the Nuix platform, and improvements in overall operating efficiency and extracting potential benefits of increased scale."

"In addition, Nuix believes that growth can be accelerated by focusing on building a network of strategic partners to provide complementary delivery and market expansion capabilities, as well as through a considered approach to value accretive mergers and acquisitions," he concluded.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 broke its losing streak to inch higher today.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Consumer Staples & Discretionary Shares

Bapcor shares soar 12% on the appointment of a new CEO

The market’s strong reaction reflects a clear message: investors are ready for a reset.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why Bapcor, IDP Education, Netwealth, and Ora Banda shares are pushing higher today

These shares are catching the eye with solid gains on Thursday. But why are they rising?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »